The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Your favorite toys and weight-loss drugs could be priced out of reach if Donald Trump is serious. Denmark’s defiant message ...

Ozempic y Wegovy son dos medicamentos muy populares para la diabetes y la pérdida de peso, respectivamente. Ambos podrían estar relacionados con un menor riesgo de padecer adicciones, así como otros ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy. The notice was issued on Tuesday ...

With Trump taking office, questions arise about Medicare price negotiations for Ozempic, Wegovy Mexico president stresses defense of country's sovereignty, in initial response to Trump orders ...

He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again for state employees, future premium increases and more. Briner announced soon after taking office ...

GLP-1 medications such as Ozempic, Wegovy and Mounjaro can help people to lose more than a fifth of their body weight and have been linked to a range of health benefits – but also some concerns.

Having made waves the world over, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly’s tirzepatide are set to enter the Indian ...